Back to SKYE

Versant Venture Management, LLC → SKYE

Versant Venture Management, LLC SKYE Position History

Skye Bioscience, Inc. • Healthcare

Quarters held
4
Latest value
$404K
Q3 2026
Peak value
$1.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$1.5M
Q1 2026$1.2M
Q2 2026$1.4M
Q3 2026$404K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$404K251.0K——
Q2 2026$1.4M2.01M——
Q1 2026$1.2M2.01M——
Q4 2025$1.5M2.01M——

Other funds holding SKYE

Other Versant Venture Management, LLC positions

MNST

Monte Rosa Therapeutics, Inc.

$77M
MNST

Monte Rosa Therapeutics, Inc.

$68.7M
MNST

Monte Rosa Therapeutics, Inc.

$52.3M
LENZ

Lenz Therapeutics, Inc.

$42.5M
MNST

Monte Rosa Therapeutics, Inc.

$37.9M
CRNC

Century Therapeutics, Inc.

$29.8M
CRNC

Century Therapeutics, Inc.

$27.5M
LENZ

Lenz Therapeutics, Inc.

$24.3M